» Articles » PMID: 24271012

Calcium Binding is Essential for Plastin 3 Function in Smn-deficient Motoneurons

Overview
Journal Hum Mol Genet
Date 2013 Nov 26
PMID 24271012
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

The actin-binding and bundling protein, plastin 3 (PLS3), was identified as a protective modifier of spinal muscular atrophy (SMA) in some patient populations and as a disease modifier in animal models of SMA. How it functions in this process, however, is not known. Because PLS3 is an actin-binding/bundling protein, we hypothesized it would likely act via modification of the actin cytoskeleton in axons and neuromuscular junctions to protect motoneurons in SMA. To test this, we examined the ability of other known actin cytoskeleton organizing proteins to modify motor axon outgrowth phenotypes in an smn morphant zebrafish model of SMA. While PLS3 can fully compensate for low levels of smn, cofilin 1, profilin 2 and α-actinin 1 did not affect smn morphant motor axon outgrowth. To determine how PLS3 functions in SMA, we generated deletion constructs of conserved PLS3 structural domains. The EF hands were essential for PLS3 rescue of smn morphant phenotypes, and mutation of the Ca(2+)-binding residues within the EF hands resulted in a complete loss of PLS3 rescue. These results indicate that Ca(2+) regulation is essential for the function of PLS3 in motor axons. Remarkably, PLS3 mutants lacking both actin-binding domains were still able to rescue motor axons in smn morphants, although not as well as full-length PLS3. Therefore, PLS3 function in this process may have an actin-independent component.

Citing Articles

Treating neuromuscular diseases: unveiling gene therapy breakthroughs and pioneering future applications.

Wu Y, Chen J, Jong Y J Biomed Sci. 2025; 32(1):30.

PMID: 39985020 PMC: 11844187. DOI: 10.1186/s12929-025-01123-z.


Cytoskeleton dysfunction of motor neuron in spinal muscular atrophy.

Shi T, Zhou Z, Xiang T, Suo Y, Shi X, Li Y J Neurol. 2024; 272(1):19.

PMID: 39666039 PMC: 11638312. DOI: 10.1007/s00415-024-12724-3.


Osteoclast-specific Plastin 3 knockout in mice fail to develop osteoporosis despite dramatic increased osteoclast resorption activity.

Maus I, Dreiner M, Zetzsche S, Metzen F, Ross B, Mahlich D JBMR Plus. 2024; 8(1):ziad009.

PMID: 38549711 PMC: 10971598. DOI: 10.1093/jbmrpl/ziad009.


Modeling Spinal Muscular Atrophy in Zebrafish: Current Advances and Future Perspectives.

Gonzalez D, Vasquez-Doorman C, Luna A, Allende M Int J Mol Sci. 2024; 25(4).

PMID: 38396640 PMC: 10888324. DOI: 10.3390/ijms25041962.


The intricate mechanism of PLS3 in bone homeostasis and disease.

Zhong W, Pathak J, Liang Y, Zhytnik L, Pals G, Eekhoff E Front Endocrinol (Lausanne). 2023; 14:1168306.

PMID: 37484945 PMC: 10361617. DOI: 10.3389/fendo.2023.1168306.


References
1.
Miyakawa T, Shinomiya H, Yumoto F, Miyauchi Y, Tanaka H, Ojima T . Different Ca²⁺-sensitivities between the EF-hands of T- and L-plastins. Biochem Biophys Res Commun. 2012; 429(3-4):137-41. DOI: 10.1016/j.bbrc.2012.10.126. View

2.
Lefebvre S, Burglen L, Reboullet S, Clermont O, Burlet P, Viollet L . Identification and characterization of a spinal muscular atrophy-determining gene. Cell. 1995; 80(1):155-65. DOI: 10.1016/0092-8674(95)90460-3. View

3.
Prior T, Swoboda K, Scott H, Hejmanowski A . Homozygous SMN1 deletions in unaffected family members and modification of the phenotype by SMN2. Am J Med Genet A. 2004; 130A(3):307-10. PMC: 4349519. DOI: 10.1002/ajmg.a.30251. View

4.
Witke W, Hofmann A, Koppel B, Schleicher M, Noegel A . The Ca(2+)-binding domains in non-muscle type alpha-actinin: biochemical and genetic analysis. J Cell Biol. 1993; 121(3):599-606. PMC: 2119564. DOI: 10.1083/jcb.121.3.599. View

5.
Ikeda H, Sasaki Y, Kobayashi T, Suzuki H, Mita H, Toyota M . The role of T-fimbrin in the response to DNA damage: silencing of T-fimbrin by small interfering RNA sensitizes human liver cancer cells to DNA-damaging agents. Int J Oncol. 2005; 27(4):933-40. View